Thermo Fisher Scientific Inc – Consensus Indicates Potential 6.8% Upside

Broker Ratings

Thermo Fisher Scientific Inc found using ticker (TMO) have now 19 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 550 and 260 with a mean TP of 500.37. Given that the stocks previous close was at 468.59 this would imply there is a potential upside of 6.8%. The day 50 moving average is 465.39 while the 200 day moving average is 402.98. The market capitalisation for the company is $191,826m. Visit the company website at: http://www.thermofisher.com

Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrödinger to expand structure-based drug discovery to novel targets using Cryo-EM; an agreement with Daiichi Sankyo; and collaboration with Northeastern University. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits
You might also enjoy reading  Thermo Fisher Scientific Inc - Consensus Indicates Potential 24.7% Upside

Good news travels fast (but only if you make that happen). Share on:

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index